NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/04/2025
Back to search
Official data from USPTO
REFINEDSCIENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
REFINEDSCIENCE
ST13
US500000098142547Class
35, 42
Filing
98142547
Registration
7682112
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
02/04/2025
Trademark type
Word
Nice classes
35, 42
Filing date
08/21/2023
Registration date
02/04/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/04/2025
Last transaction
02/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/10/2024
First use in commerce
01/10/2024
Drawing code
4
Owner type
16
Owner location
Aurora, CO
Examiner
QUILICI, BRENDAN
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
AML JV, LLC
Representatives
Nicole Swartz SETTER ROCHE SMITH & SHELLENBERGER LLP
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of clinical trialsproviding information management services; Business consulting and management in the field of clinical trialsmanagement and compilation of computerized databases in the field of clinical trials for business purposes; Providing independent review of clinical trials for business purposes
Class 42
Compiling data for research purposes in the field of medical science and medical consultancy; Consultancy in the field of artificial intelligence technology; Consulting services in the field of pharmaceutical research and development; Pharmaceutical drug development services; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Software as a service (SAAS) services featuring software using artificial intelligence for predicting clinical pharmaceutical trial success and for tracking and predicting biomarker and biosignature identifications in clinical pharmaceutical trials; Software design and development; Technical consulting in the field of artificial intelligence (AI) software customization; Technical support servicesremote and on-site infrastructure management services for monitoringadministration and management of public and private cloud computing IT and application systems
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/04/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/14/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/14/2025
DOCK
ASSIGNED TO EXAMINER
12/10/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/06/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/05/2024
IUAF
USE AMENDMENT FILED
09/24/2024
EISU
TEAS STATEMENT OF USE RECEIVED
09/24/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/30/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/04/2024
PUBO
PUBLISHED FOR OPPOSITION
06/04/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/15/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/29/2024
DOCK
ASSIGNED TO EXAMINER
04/19/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/19/2023
NWAP
NEW APPLICATION ENTERED
08/25/2023
Continuous trademark protection
Get notified about every new filing that threatens REFINEDSCIENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.